Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62.7M
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
29.1M
-
Shares change
-
+5.82M
-
Total reported value, excl. options
-
$932M
-
Value change
-
+$174M
-
Put/Call ratio
-
0.79
-
Number of buys
-
94
-
Number of sells
-
-43
-
Price
-
$32.06
Significant Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q1 2016
162 filings reported holding SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") as of Q1 2016.
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.1M shares
of 62.7M outstanding shares and own 46.4% of the company stock.
Largest 10 shareholders include FMR LLC (4.8M shares), VANGUARD GROUP INC (1.62M shares), Visium Asset Management, LP (1.56M shares), FRANKLIN RESOURCES INC (1.29M shares), DEERFIELD MANAGEMENT CO (1.11M shares), Redmile Group, LLC (1.05M shares), JPMORGAN CHASE & CO (1.03M shares), ALLIANCEBERNSTEIN L.P. (948K shares), Cormorant Asset Management, LLC (945K shares), and EAGLE ASSET MANAGEMENT INC (847K shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.